stars 1 stars 2 stars 3

Amicrobe is developing a new generation of locally applied products to prevent and treat life-threatening infections. Our powerful technology platform, called Amicidins™, brings the upside potential of breakthrough biotech products with the reduced commercial risk of multi-use materials. Amicidins are synthetic proteins engineered for local application. They combine beneficial physical properties and microbicidal activity against an array of pathogens. When directly applied to vulnerable tissues “inside the body”, Amicidins can block contamination before it occurs or treat contamination/infection to help stop disease progression.

Amicrobe, Inc. Questions

The Amicrobe, Inc. annual revenue was $7 million in 2026.

Amicrobe, Inc. is based in Carlsbad, California.

The NAICS codes for Amicrobe, Inc. are [54, 325, 32, 541, 5417].

The SIC codes for Amicrobe, Inc. are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users